RheumaGen Named Colorado’s Most Innovative Emerging Company of 2023

RheumaGen was named Colorado’s Most Innovative Emerging Company of 2023 after presenting at the Colorado BioScience Association’s Innovation Showcase on October 2, 2023. RheumaGen was selected as a finalist to present, along with illumifyDx and TissueForm, Inc., and was awarded the top prize in honor of its innovative approach to HLA gene editing to treat autoimmune diseases.

Learn more here.

Previous
Previous

RheumaGen Awarded Grant from Colorado Office of Economic Development

Next
Next

RheumaGen’s Innovative Approach to Rheumatoid Arthritis Treatment Featured on CBS News